Page 123 - 202014

and plasma olanzapine concentration，based on pharmaco- 2010，42（2）：268-354.
genetics： Juntendo University schizophrenia projects [28] EAP CB，BENDER S，SIROT EJ，et al. Nonresponse to
（JUSP）[J]. Ther Drug Monit，2008，30（1）：35-40. clozapine and ultrarapid CYP1A2 activity：clinical data
[18] SIROT EJ，KNEZEVIC B，MORENA GP，et al. ABCB1 and analysis of CYP1A2 gene[J]. J Clin Psychopharma-
and cytochrome P450 polymorphisms：clinical pharmacoge- col，2004，24（2）：214-219.
netics of clozapine[J]. J Clin Psychopharmacol，2009，29 [29] TSANG MW，SHADER RI，GREENBLATT DJ. Metabo-
（4）：319-326. lism of haloperidol：clinical implications and unanswered
[19] GHOTBI R，MANNHEIMER B，AKLILLU E，et al. Carri- questions[J]. J Clin Psychopharmacol，1994，14（3）：159-
ers of the UGT1A4 142T＞G gene variant are predis- 162.
posed to reduced olanzapine exposure：an impact similar [30] OHARA K，TANABU S，YOSHIDA K，et al. Effects of
to male gender or smoking in schizophrenic patients[J]. smoking and cytochrome P450 2D6*10 allele on the plas-
Eur J Clin Pharmacol，2010，66（5）：465-474. ma haloperidol concentration/dose ratio[J]. Prog Neuro-
[20] LAIKA B，LEUCHT S，HERES S，et al. Pharmacogenet- psychopharmacol Biol Psychiatry，2003，27（6）：945-949.
ics and olanzapine treatment：CYP1A2*1F and serotoner- [31] FANG J，SONG J. In vitro Characterization of the oxida-
gic polymorphisms influence therapeutic outcome[J]. tion of a pyridinium metabolite of haloperidol by human
Pharmacogenomics J，2010，10（1）：20-29. placenta：the effect of smoking[J]. J Pharm Pharm Sci，
[21] RAJKUMAR AP，POONKUZHALI B，KURUVILLA A， 2012，15（4）：538-547.
et al. Association between CYP1A2 gene single nucleo- [32] LINNET K，OLESEN OV. Free and glucuronidated olan-
tide polymorphisms and clinical responses to clozapine in zapine serum concentrations in psychiatric patients：influ-
patients with treatment-resistant schizophrenia[J]. Acta ence of carbamazepine comedication[J]. Ther Drug Monit，
Neuropsychiatr，2013，25（1）：2-11. 2002，24（4）：512-517.
[22] CZERWENSKY F，LEUCHT S，STEIMER W. CYP1A2*1D [33] SINGH A，BENIWAL RP，KUKSHAL P，et al. A prelimi-
and *1F polymorphisms have a significant impact on olan- nary study of association of genetic variants with early re-
zapine serum concentrations[J]. Ther Drug Monit，2015， sponse to olanzapine in schizophrenia[J]. Indian J Psychi-
37（2）：152-160. atry，2018，60（1）：10-16.
[23] OLSSON E，EDMAN G，BERTILSSON L，et al. Genetic [34] 宋炜宸，禹顺英.抗精神病药物个体差异的全基因组关联
and clinical factors affecting plasma clozapine concentra- 分析研究进展[J].中国神经精神疾病杂志，2018，44
tion[J]. Prim Care Companion CNS Disord，2015. DOI： （11）：697-701.
10.4088/PCC.14m01704. [35] TSUDA Y，SARUWATARI J，YASUI-FURUKORI N. Me-
[24] HUANG HC，LUA AC，WU LS，et al. Cigarette smoking ta-analysis：the effects of smoking on the disposition of
has a differential effect on the plasma level of clozapine in two commonly used antipsychotic agents，olanzapine and
Taiwanese schizophrenic patients associated with the clozapine[J]. BMJ Open，2014. DOI：10.1136/bmjopen-
CYP1A2 gene － 163A/C single nucleotide polymor- 2013-004216.
phism[J]. Psychiatr Genet，2016，26（4）：172-177. [36] KENNEDY MJ，DAVIS DA，SMITH N，et al. Reduced ac-
[25] SOYAMA A，SAITO Y，HANIOKA N，et al. Single nucle- tivities of cytochrome P450 1A2 and xanthine oxidase in
otide polymorphisms and haplotypes of CYP1A2 in a Jap- children with growth hormone deficiency[J]. Clin Pharma-
anese population[J]. Drug Metab Pharmacokinet，2005，20 col Ther，2008，84（6）：674-678.
（1）：24-33. [37] PATEL MX，BOWSKILL S，COUCHMAN L，et al. Plas-
[26] MURAYAMA N，SOYAMA A，SAITO Y，et al. Six novel ma olanzapine in relation to prescribed dose and other fac-
nonsynonymous CYP1A2 gene polymorphisms：catalytic tors：data from a therapeutic drug monitoring service，
activities of the naturally occurring variant enzymes[J]. J 1999-2009[J]. J Clin Psychopharmacol，2011，31（4）：411-
Pharmacol Exp Ther，2004，308（1）：300-306. 417.
[27] ZHOU SF，WANG B，YANG LP，et al. Structure，func- （收稿日期：2020-02-26 修回日期：2020-05-24）
tion，regulation and polymorphism and the clinical signifi- （编辑：陈 宏）
cance of human cytochrome P450 1A2[J]. Drug Metab Rev，

中国药房 2020年第31卷第14期 China Pharmacy 2020 Vol. 31 No. 14 ·1777 ·